Highly pathogenic avian influenza A/Guangdong/17SF003/2016 is immunogenic and induces cross-protection against antigenically divergent H7N9 viruses
出版年份 2021 全文链接
标题
Highly pathogenic avian influenza A/Guangdong/17SF003/2016 is immunogenic and induces cross-protection against antigenically divergent H7N9 viruses
作者
关键词
-
出版物
npj Vaccines
Volume 6, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-02-26
DOI
10.1038/s41541-021-00295-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Evaluation of the immune response of a H7N9 candidate vaccine virus derived from the fifth wave A/Guangdong/17SF003/2016
- (2020) Ji Dong et al. ANTIVIRAL RESEARCH
- Recombinant HA-based vaccine outperforms split and subunit vaccines in elicitation of influenza-specific CD4 T cells and CD4 T cell-dependent antibody responses in humans
- (2020) K. A. Richards et al. npj Vaccines
- Broadly cross-reactive, non-neutralizing antibodies against the influenza B virus hemagglutinin demonstrate effector function dependent protection against lethal viral challenge in mice
- (2019) Guha Asthagiri Arunkumar et al. JOURNAL OF VIROLOGY
- Novel correlates of protection against pandemic H1N1 influenza A virus infection
- (2019) Sophia Ng et al. NATURE MEDICINE
- Imprinting of Repeated Influenza A/H3 Exposures on Antibody Quantity and Antibody Quality: Implications on Seasonal Vaccine Strain Selection and Vaccine Performance
- (2018) Martina Kosikova et al. CLINICAL INFECTIOUS DISEASES
- Risk Assessment of Fifth-Wave H7N9 Influenza A Viruses in Mammalian Models
- (2018) Xiangjie Sun et al. JOURNAL OF VIROLOGY
- Potency determination of inactivated H7 influenza vaccines using monoclonal antibody-based ELISA and biolayer interferometry assays
- (2017) Anupama Vasudevan et al. Influenza and Other Respiratory Viruses
- Human infections with recently-emerging highly pathogenic H7N9 avian influenza virus in China
- (2017) Fuchun Zhang et al. JOURNAL OF INFECTION
- A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus
- (2017) Nicholas C. Wu et al. JOURNAL OF MOLECULAR BIOLOGY
- Emergence and Adaptation of a Novel Highly Pathogenic H7N9 Influenza Virus in Birds and Humans from a 2013 Human-Infecting Low-Pathogenic Ancestor
- (2017) Wenbao Qi et al. JOURNAL OF VIROLOGY
- Safety and immunogenicity of an inactivated cell culture-derived H7N9 influenza vaccine in healthy adults: A phase I/II, prospective, randomized, open-label trial
- (2017) Un-In Wu et al. VACCINE
- The immune correlates of protection for an avian influenza H5N1 vaccine in the ferret model using oil-in-water adjuvants
- (2017) Sook-San Wong et al. Scientific Reports
- Update: Increase in Human Infections with Novel Asian Lineage Avian Influenza A(H7N9) Viruses During the Fifth Epidemic — China, October 1, 2016–August 7, 2017
- (2017) James C. Kile et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans
- (2017) Daniel Stadlbauer et al. mSphere
- H5N1 influenza vaccine induces a less robust neutralizing antibody response than seasonal trivalent and H7N9 influenza vaccines
- (2017) Sook-San Wong et al. npj Vaccines
- Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection
- (2016) Carole J. Henry Dunand et al. Cell Host & Microbe
- Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults
- (2016) Anuradha Madan et al. JOURNAL OF INFECTIOUS DISEASES
- Differences in the Epidemiology of Human Cases of Avian Influenza A(H7N9) and A(H5N1) Viruses Infection
- (2015) Ying Qin et al. CLINICAL INFECTIOUS DISEASES
- Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response
- (2015) Lisa A. Jackson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of Adjuvants on the Immunogenicity and Efficacy of Split-Virion H7N9 Vaccine in Ferrets
- (2015) Sook-San Wong et al. JOURNAL OF INFECTIOUS DISEASES
- Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus
- (2015) Peter Pushko et al. VACCINE
- Antibodies to Antigenic Site A of Influenza H7 Hemagglutinin Provide Protection against H7N9 Challenge
- (2015) Falko Schmeisser et al. PLoS One
- An H7N1 Influenza Virus Vaccine Induces Broadly Reactive Antibody Responses against H7N9 in Humans
- (2014) Florian Krammer et al. Clinical and Vaccine Immunology
- Serological Responses to an Avian Influenza A/H7N9 Vaccine Mixed at the Point-of-Use With MF59 Adjuvant
- (2014) Mark J. Mulligan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Cell Culture-Derived MF59-Adjuvanted Pandemic A/H7N9 Vaccine Is Immunogenic in Adults
- (2014) S. A. Bart et al. Science Translational Medicine
- Kinetics of serological responses in influenza A(H7N9)-infected patients correlate with clinical outcome in China, 2013
- (2013) A Zhang et al. Eurosurveillance
- Hemagglutinin Stalk-Based Universal Vaccine Constructs Protect against Group 2 Influenza A Viruses
- (2013) I. Margine et al. JOURNAL OF VIROLOGY
- Antibody-Dependent Cellular Cytotoxicity Is Associated with Control of Pandemic H1N1 Influenza Virus Infection of Macaques
- (2013) S. Jegaskanda et al. JOURNAL OF VIROLOGY
- Human infection with avian influenza A H7N9 virus: an assessment of clinical severity
- (2013) Hongjie Yu et al. LANCET
- A Recombinant Viruslike Particle Influenza A (H7N9) Vaccine
- (2013) Louis F. Fries et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China
- (2013) Qun Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessment of viral replication in eggs and HA protein yield of pre-pandemic H5N1 candidate vaccine viruses
- (2013) Xianghong Jing et al. VACCINE
- Global Mortality Estimates for the 2009 Influenza Pandemic from the GLaMOR Project: A Modeling Study
- (2013) Lone Simonsen et al. PLOS MEDICINE
- Cooperativity Between CD8+ T Cells, Non-Neutralizing Antibodies, and Alveolar Macrophages Is Important for Heterosubtypic Influenza Virus Immunity
- (2013) Brian J. Laidlaw et al. PLoS Pathogens
- A Carboxy-Terminal Trimerization Domain Stabilizes Conformational Epitopes on the Stalk Domain of Soluble Recombinant Hemagglutinin Substrates
- (2012) Florian Krammer et al. PLoS One
- Evaluations for In Vitro Correlates of Immunogenicity of Inactivated Influenza A H5, H7 and H9 Vaccines in Humans
- (2012) Robert B. Couch et al. PLoS One
- Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses
- (2012) N. Pica et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Revisiting the 1976 "Swine Flu" Vaccine Clinical Trials: Cross-reactive Hemagglutinin and Neuraminidase Antibodies and Their Role in Protection Against the 2009 H1N1 Pandemic Virus in Mice
- (2011) H. Xie et al. CLINICAL INFECTIOUS DISEASES
- Comparative Efficacy of Neutralizing Antibodies Elicited by Recombinant Hemagglutinin Proteins from Avian H5N1 Influenza Virus
- (2008) C.-J. Wei et al. JOURNAL OF VIROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started